India's Natco Pharma surges on favourable US court ruling for Teva Pharmaceutical Industries

Comments 0
Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling. Reuters Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling. Reuters
SummaryShares in Natco Pharma surge 6 pct after prospects for its generic version for Teva Pharmaceutical Industries.

Shares in India's Natco Pharma Ltd surge 6 percent after prospects for its generic version for Teva Pharmaceutical Industries' billion dollar drug got a boost from a favourable US court ruling on Wednesday.

An US Supreme Court justice on Wednesday declined a request from Teva for a stay of an appeals court ruling that would strip the company's $4 billion-a-year multiple sclerosis drug Copaxone of patent protection in 2014, rather than in 2015.

In July, the US Court of Appeals for the Federal Circuit issued a decision in a patent fight that pits Teva against two teams developing cheaper generic forms of Copaxone: one with Novartis AG and Momenta Pharmaceuticals Inc ; and another between Mylan Inc and Natco Pharma.

Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...